Aurobindo Pharma to acquire entire stake in MViyeS

19 Oct 2020 Evaluate

Aurobindo Pharma has entered into a share purchase agreement to acquire 100% equity share capital of MViyeS Pharma Ventures (MViyeS). MViyeS is holding 32.18% shareholding in Eugia Pharma Specialities, a joint venture company in which the Company is holding 67.82%.

By this acquisition, both Eugia Pharma Specialities and MViyeS Pharma Ventures will become 100% subsidiaries of the Company.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1086.00 2.40 (0.22%)
25-Apr-2024 10:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1513.55
Dr. Reddys Lab 5995.00
Cipla 1398.25
Zydus Lifesciences 930.50
Lupin 1593.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.